News
The interaction between a common gene variant and gut microbes may trigger chronic inflammation in ulcerative colitis, new ...
Ulcerative colitis is a form of inflammatory bowel disease (IBD) that causes inflammation and open sores (ulcers) in the ...
Among the new options is filgotinib, an oral medication that has become the most-used first-line therapy since 2021. Unlike ...
American depositary receipts of French biotechnology firm Abivax rose more than sixfold premarket after a drug candidate for bowel condition ulcerative colitis showed promise in a late-stage clinical ...
Coconut water might be more than just a refreshing drink as it could offer relief for people battling ulcerative colitis, a chronic inflammatory bowel disease that raises the risk of bowel cancer.
Abivax SA (NASDAQ:ABVX) stock is skyrocketing on Wednesday after the clinical-stage biotechnology company announced ...
Abivax shares surged 500% after positive phase 3 results for obefazimod in moderate-to-severe ulcerative colitis. Click here ...
Ulcerative colitis, a chronic inflammatory bowel disease, presents treatment challenges due to its variable symptoms and unpredictable flare-ups. The global market is set to grow, driven by biologic ...
Marisa Marinelli was told her colon might need to be removed to heal her ulcerative colitis. At 29, she was diagnosed with ...
Abivax has shared positive top-line results from two late-stage studies of its investigational oral miR-124 enhancer in adults with moderately to severely active ulcerative colitis (UC).
It has been a stellar week for Abivax, a French biotech developing therapeutics that harness the body’s natural regulatory ...
A low-emulsifier-containing diet led to a threefold increased likelihood of improvement in symptoms of Crohn’s disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results